sorry, we can't preview this file
Figure7.eps (11.71 kB)
Figure 7. SOX15 overexpression increases PGCLC fraction.
figure
posted on 2019-07-25, 15:52 authored by Merrick Pierson SmelaMerrick Pierson Smela, Anastasiya Sybirna, M. Azim SuraniFigure 7. SOX15 overexpression increases PGCLC fraction. EBs were treated with Shield1 starting at the beginning of induction, and PGCLC fraction was measured by flow cytometry on day 4, 6, or 8. Significance values are by Wilcoxon test (* p < 0.05, ** p < 0.01, ***p < 0.001)
Funding
Core funding for Wellcome Trust / Cancer Research UK Gurdon Institute
Cancer Research UK
Find out more...